Form 4: Anne M. Mulcahy Reports Acquisition of Deferred Share Units in Johnson & Johnson

Director Anne M. Mulcahy reports the acquisition of deferred share units in Johnson & Johnson, to be settled in cash upon termination of directorship.

Summary

• Anne M. Mulcahy, a director of Johnson & Johnson, filed a Form 4 on April 29, 2024, reporting a transaction.
• On April 25, 2024, Mulcahy acquired 1,385.697 deferred share units (DSUs) under the Issuer's Amended and Restated Deferred Fee Plan for Directors.
• These DSUs will be settled in cash upon termination of Mulcahy's directorship, with each DSU representing the fair market value of one share of Common Stock on the settlement date.
• Following the reported transaction, Mulcahy beneficially owns 21,470.618 derivative securities, which includes dividend equivalent rights accrued on the DSUs.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing, indicating a neutral sentiment. It reports a transaction by a company director, which is a routine occurrence.

Positives

• The acquisition of deferred share units aligns the director's interests with the long-term performance of the company.
• The deferred fee plan for directors is a common practice to attract and retain qualified board members.

Future Outlook

The deferred share units will be settled in cash upon termination of the Reporting Person's directorship.

Industry Context

Form 4 filings are standard practice for reporting changes in beneficial ownership by company insiders, providing transparency to investors.

Stakeholder Impact

• Shareholders are informed about changes in beneficial ownership by company insiders.
• The transaction has a minimal direct impact on employees, customers, suppliers, or creditors.

Key Dates